Honest Thoughts on the Psychedelic Science 2023 Summit

New study brings hope to cancer patients struggling with depressive symptoms. Conflicts in Kentucky commission developing plan to fund research on the benefits of ibogaine to treat opioid addiction. Ayahuasca played a key role in finding Colombian children stranded in the Amazonian jungle.

Otsuka’s ADHD asset succeeds in registrational trials with children and teens

Otsuka Pharmaceutical’s ADHD drug candidate has met its goal in a pair of Phase III trials focused on children and teens with the neurodevelopmental condition,

October 28, 2023

Radionuclide-Containing Combo Slows Metastatic Prostate Cancer, Improves Survival

Men with castration-resistant prostate cancer (CRPC) and asymptomatic or mildly symptomatic bone metastases lived significantly longer when they received enzalutamide (Xtandi) plus radium-223 (Ra-223, Xofigo),

September 16, 2024

Nuclear Medicine Specialist Ken Herrmann Joins Supervisory Board of Pentixapharm Holding AG – Biotech Investments

EQS-News: Pentixapharm Holding AG / Key word(s): Personnel Nuclear Medicine Specialist Ken Herrmann Joins Supervisory Board of Pentixapharm Holding AG 28.10.2024 / 12:26 CET/CEST The

October 29, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.